RxSight (NASDAQ:RXST) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.22) by 86.36 percent. This is a 75 percent increase over losses of $(0.12) per share from the same period last year. The company reported quarterly sales of $37.90 million which missed the analyst consensus estimate of $38.12 million by 0.58 percent. This is a 28.41 percent increase over sales of $29.51 million the same period last year.